Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Morikawa

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|August 14, 2020
Poly(hydroxyurethane): catalytic applicability for the cyclic carbonate synthesis from epoxides and CO<sub>2</sub>Suguru Motokucho, Hiroshi Morikawa
Nihon Jibiinkoka Gakkai Kaiho|September 30, 2003
[The kinetics of CD80 and CD86 expression on antigen-presenting cells in cedar pollinosis subjects]Kunitaka Shirasaka, Hiroshi Morikawa
Biomedical Chromatography : BMC|October 16, 2004
Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometryToshihiro Oguma, Hiroshi Morikawa, Daisuke Iwasaki, et al.
Journal of the American Chemical Society|November 6, 2003
Magnetic properties of tetrakis[4-(alpha-diazobenzyl)pyridine]bis(thiocyanato-N)cobalt(II) in frozen solution after irradiation. Formation of a single-molecule magnet in frozen solutionSatoru Karasawa, Guangyuan Zhou, Hiroshi Morikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 4, 2004
[Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer]Shinichi Nakanishi, Masato Matsuzaki, Hiroshi Morikawa, et al.
Chirality|September 19, 2002
Enantiomeric recognition of amino acids using a chiral spiropyran derivativeKazunori Tsubaki, Koichiro Mukoyoshi, Hiroshi Morikawa, et al.
Drug Metabolism and Pharmacokinetics|May 12, 2009
Tissue-specific mRNA expression profiles of drug-metabolizing enzymes and transporters in the cynomolgus monkeyMasuhiro Nishimura, Akiko Koeda, Hiroshi Morikawa, et al.
Biological & Pharmaceutical Bulletin|November 5, 2008
Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytesMasuhiro Nishimura, Akiko Koeda, Hiroshi Morikawa, et al.
JMIR Cardio|October 6, 2025
Validity of Heart Rate Measurement Using Wearable Devices During Cardiopulmonary Exercise Testing in Patients With Cardiovascular Disease: Prospective Pilot Validation StudyKazufumi Kitagaki, Yuji Hongo, Rie Futai, et al.
Cureus|August 28, 2025
Physical Frailty as a Barrier to Improvements in Physical Performance in Older Patients With Heart Failure Undergoing Acute-Phase Cardiac RehabilitationYuji Hongo, Kazufumi Kitagaki, Rie Futai, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|August 14, 2020
Poly(hydroxyurethane): catalytic applicability for the cyclic carbonate synthesis from epoxides and CO<sub>2</sub>Suguru Motokucho, Hiroshi Morikawa
Nihon Jibiinkoka Gakkai Kaiho|September 30, 2003
[The kinetics of CD80 and CD86 expression on antigen-presenting cells in cedar pollinosis subjects]Kunitaka Shirasaka, Hiroshi Morikawa
Biomedical Chromatography : BMC|October 16, 2004
Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometryToshihiro Oguma, Hiroshi Morikawa, Daisuke Iwasaki, et al.
Journal of the American Chemical Society|November 6, 2003
Magnetic properties of tetrakis[4-(alpha-diazobenzyl)pyridine]bis(thiocyanato-N)cobalt(II) in frozen solution after irradiation. Formation of a single-molecule magnet in frozen solutionSatoru Karasawa, Guangyuan Zhou, Hiroshi Morikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 4, 2004
[Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer]Shinichi Nakanishi, Masato Matsuzaki, Hiroshi Morikawa, et al.
Chirality|September 19, 2002
Enantiomeric recognition of amino acids using a chiral spiropyran derivativeKazunori Tsubaki, Koichiro Mukoyoshi, Hiroshi Morikawa, et al.
Drug Metabolism and Pharmacokinetics|May 12, 2009
Tissue-specific mRNA expression profiles of drug-metabolizing enzymes and transporters in the cynomolgus monkeyMasuhiro Nishimura, Akiko Koeda, Hiroshi Morikawa, et al.
Biological & Pharmaceutical Bulletin|November 5, 2008
Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytesMasuhiro Nishimura, Akiko Koeda, Hiroshi Morikawa, et al.
JMIR Cardio|October 6, 2025
Validity of Heart Rate Measurement Using Wearable Devices During Cardiopulmonary Exercise Testing in Patients With Cardiovascular Disease: Prospective Pilot Validation StudyKazufumi Kitagaki, Yuji Hongo, Rie Futai, et al.
Cureus|August 28, 2025
Physical Frailty as a Barrier to Improvements in Physical Performance in Older Patients With Heart Failure Undergoing Acute-Phase Cardiac RehabilitationYuji Hongo, Kazufumi Kitagaki, Rie Futai, et al.
Pageof 3